TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis.

TRP channels and temperature in airway disease-clinical significance. Temperature (Austin) (2015) 0.86

The role of TRPV1 in the CD4+ T cell-mediated inflammatory response of allergic rhinitis. Oncotarget (2016) 0.80

TRPV1 and TRPM8 in Treatment of Chronic Cough. Pharmaceuticals (Basel) (2016) 0.78

Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. Am Heart J (2005) 1.46

Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J (2003) 1.10

Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human. Pulm Pharmacol Ther (2006) 0.92

Correlation of skin blanching and percutaneous absorption for glucocorticoid receptor agonists by matrix-assisted laser desorption ionization mass spectrometry imaging and liquid extraction surface analysis with nanoelectrospray ionization mass spectrometry. Anal Chem (2010) 0.89

Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir Med (2009) 0.88

Patient Advice and Liaison Services: strengthening the voices of individual service users in health-care organizations. Health Expect (2006) 0.86

Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig. Br J Pharmacol (2013) 0.86

Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor. Br J Clin Pharmacol (2013) 0.86

Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. Ann Allergy Asthma Immunol (2008) 0.85

Quality criteria for patient advice and liaison services: what do patients and the public want? Health Expect (2005) 0.83

Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol (2014) 0.80

Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis. Allergy Asthma Proc (2011) 0.80

The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers. Eur J Drug Metab Pharmacokinet (2014) 0.79

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis. Int J Clin Pharmacol Ther (2013) 0.79

Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates. Anal Biochem (2008) 0.79

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study. Respir Res (2013) 0.78

Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge. J Allergy Clin Immunol (2011) 0.77

Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber. Int J Clin Pharmacol Ther (2015) 0.76

Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations. Nucleic Acid Ther (2012) 0.76

Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. Curr Med Res Opin (2008) 0.76

Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model. Allergy Asthma Proc (2012) 0.76

Can GPs and PALS be friends? Br J Gen Pract (2003) 0.75

Interprofessional care co-ordinators: the benefits and tensions associated with a new role in UK acute health care. Int J Nurs Stud (2003) 0.75

Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear Nose Throat J (2008) 0.75

Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
. Int J Clin Pharmacol Ther (2017) 0.75

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers. Clin Ther (2006) 0.75